Persistence of long-term immunity to hepatitis B among adolescents immunized at birth

Vaccine

Volumn 30, Issue 9, 2012, Pages 1644-1649

  Chaves, Sandra S ^a   Fischer, Gayle ^a   Groeger, Justina ^a   Patel, Priti R ^a   Thompson, Nicola D ^a   Teshale, Eyasu H ^a   Stevenson, Kuartei ^b   Yano, Victor M ^b   Armstrong, Gregory L ^a   Samandari, Taraz ^a   Kamili, Saleem ^a   Drobeniuc, Jan ^a   Hu, Dale J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Republic of Palau Ministry of Health   (Palau)

Author keywords

Anamnestic response; Hepatitis B vaccination; Hepatitis B virus; Long term immunity

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BIRTH; CHILD; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; IMMUNITY; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIMARY PREVENTION; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE; VACCINATION;

ADOLESCENT; CHILD; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; MALE; VACCINES, SYNTHETIC;

EID: 84856774192     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.106     Document Type: Article

References (33)

1. Goldstein S.T., Zhou F., Hadler S.C., Bell B.P., Mast E.E., Margolis H.S. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005, 34(December (6)):1329-1333.
2. Bosch F.X., Ribes J., Cléries R., Díaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005, 9(May (2)):191-211. [v. Review].
3. Vogt T.M., Goldstein S.T., Kuartei S. Endemic hepatitis B virus infection and chronic liver disease mortality in the Republic of Palau, 1990-2002. Trans R Soc Trop Med Hyg 2006, 100(December (12)):1130-1134.
4. Chen C.J., Wang L.Y., Yu M.W. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol 2000, 15(May (Suppl.)):E3-E6.
5. Chang M.H., Chen C.J., Lai M.S., Hsu H.M., Wu T.C., Kong M.S., et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997, 336:1855-1859.
6. Kao J.H., Hsu H.M., Shau W.Y., Chang M.H., Chen D.S. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr 2001, 139:349-352.
7. Chen H.L., Chang M.H., Ni Y.H., Hsu H.Y., Lee P.I., Lee C.Y., et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 1996, 276:906-908.
8. McMahon B.J., Bulkow L.R., Singleton R.J., Williams J., Snowball M., Homan C., et al. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program. Hepatology 2011, (May). 10.1002/hep.24442.
9. McMahon B.J., Alberts S.R., Wainwright R.B., Bulkow L., Lanier A.P. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med 1990, 150(May (5)):1051-1054.
10. Beasley R.P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988, 61:1942-1956.
11. Hyams K.C. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995, 20(April (4)):992-1000. [Review].
12. Jilg W., Schmidt M., Deinhardt F. Persistence of specific antibodies after hepatitis B vaccination. J Hepatol 1988, 6(April (2)):201-207.
13. McMahon B.J., Dentinger C.M., Bruden D., Zanis C., Peters H., Hurlburt D., et al. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis 2009, 200(November (9)):1390-1396.
14. Morens DM, Polloi AH, Silberman C, Williams RP, Katz AR, Grove JS. The Palau Prevention Study Team. Report: the 1991 Palau Prevention Study: investigation of HIV-related risk behaviors in an HIV-free United States-affiliated Micronesian population. Koror: Palau Ministry of Health; 1997.
15. Kao J.T., Wang J.H., Hung C.H., Yen Y.H., Hung S.F., Hu T.H., et al. Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan. Vaccine 2009, 27(March (12)):1858-1862.
16. Lu C.Y., Ni Y.H., Chiang B.L., Chen P.J., Chang M.H., Chang L.Y., et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis 2008, 197(May (10)):1419-1426.
17. Su F.H., Cheng S.H., Li C.Y., Chen J.D., Hsiao C.Y., Chien C.C., et al. Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination. Vaccine 2007, 25(November (47)):8085-8090. 17920732.
18. Bialek S.R., Bower W.A., Novak R., Helgenberger L., Auerbach S.B., Williams I.T., et al. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a15-year follow-up study. Pediatr Infect Dis J 2008, 27(October (10)):881-885.
19. Chaves S.S., Groeger J., Helgenberger L., Auerbach S.B., Bialek S.R., Hu D.J., et al. Improved anamnestic response among adolescents boosted with a higher dose of the hepatitis B vaccine. Vaccine 2010, 28(April (16)):2860-2864.
20. Samandari T., Fiore A.E., Negus S., Williams J.L., Kuhnert W., McMahon B.J., et al. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Pediatrics 2007, 120(August (2)):e373-e381. [Epub 2007 July 16].
21. Dentinger C.M., McMahon B.J., Butler J.C., Dunaway C.E., Zanis C.L., Bulkow L.R., et al. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J 2005, 24:786-792.
22. Hammitt L.L., Hennessy T.W., Fiore A.E., Zanis C., Hummel K.B., Dunaway E., et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 2007, 25(September (39-40)):6958-6964.
23. Roznovsky L., Orsagova I., Kloudova A., Tvrdik J., Kabieszova L., Lochman I., et al. Long-term protection against hepatitis B after newborn vaccination: 20-year follow-up. Infection 2010, 38(October (5)):395-400.
24. Jan C.F., Huang K.C., Chien Y.C., Greydanus D.E., Davies H.D., Chiu T.Y., et al. Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology 2010, 51(May (5)):1547-1554.
25. Mu S.C., Lin Y.M., Jow G.M., Chen B.F. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol 2009, 50(February (2)):264-272.
26. Wu J.S., Hwang L.Y., Goodman K.J., Beasley R.P. Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis 1999, 179(June (6)):1319-1325.
27. van der Sande M.A., Waight P., Mendy M., Rayco-Solon P., Hutt P., Fulford T., et al. Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis 2006, 193(June (11)):1528-1535.
28. Reinert P., Cinquetti S., Soubeyrand B., Biasio L.R., Meghlaoui G., Thomas S., et al. Challenge with hepatitis B vaccine in children previously vaccinated with a hepatitis B-containing combination vaccine. Adv Ther 2010, 27(January (1)):28-38. [2010 February 25. Erratum in: Adv Ther 2010;27(March(3)):192].
29. Gilca V., Dionne M., Boulianne N., Murphy D., De Serres G. Long-term immunogenicity of two pediatric doses of combined hepatitis A and B or monovalent hepatitis B vaccine in 8 to 10-year-old children and the effect of a challenge dose given seven years later. Pediatr Infect Dis J 2009, 28(October (10)):916-918.
30. Sivakumar S.M., Sukumaran N., Nirmala L., Swarnalakshmi R., Anilbabu B., Siva L., et al. Immunopotentiation of hepatitis B vaccine using biodegradable polymers as an adjuvant. J Microbiol Immunol Infect 2010, 43(August (4)):265-270.
31. MacDonald L.D., Fuentes-Ortega A., Sammatur L., Mansour M. Efficacy of a single dose hepatitis B depot vaccine. Vaccine 2010, 28(October (44)):7143-7145.
32. Lee S.S., Lo Y.C., Choi M.Y., Lim W.L. Anamnestic responses of infants after regular or reduced doses of hepatitis B vaccine. J Hepatol 1995, 23(October (4)):482.
33. Lee S.S., Lo Y.C., Young B.W., Wong K.H., Lim W.L. A reduced dose approach to hepatitis B vaccination for low-risk newborns and preschool children. Vaccine 1995, 13(March (4)):373-376.